Gilead Archives - Page 21 of 21 -

Firm hopes Epclusa will give an edge over rivals.

Gilead’s latest hep C therapy approved in EU

https://pharmaphorum.com/news/gileads-latest-hep-c-therapy-approved-in-eu/

epclusabottleandtablet jpg 189656 original

News/ US

Gilead hopes cut-price pan-genomic hep C combo will revive sales

Richard Staines Epclusa, fda, Gilead, hepatitis C, sales, Sovaldi 0 Comment

Epclusa is first treatment for all six major virus genotypes.

Gilead hopes cut-price pan-genomic hep C combo will revive sales

https://pharmaphorum.com/transversal-categories/us/gilead-looks-new-hepatitis-c-combo-boost-sales/

Articles/ Views and analysis

Pharma news round-up: Pfizer-Allergan merger scrapped, Gilead to buy Nimbus Apollo, WHO diabetes campaign and more

Linda Banks Allergan, doctors' strike, Gilead, Mergers and acquisitions, Pfizer, WHO 0 Comment

A round-up of this week’s top pharma and healthcare news – plus reaction from social media. Marco Ricci

Pharma news round-up: Pfizer-Allergan merger scrapped, Gilead to buy Nimbus Apollo, WHO diabetes campaign and more

https://pharmaphorum.com/views-and-analysis/pharma-news-round-up-pfizer-allergan-merger-scrapped-gilead-to-buy-nimbus-apollo-who-diabetes-campaign-and-more/

Articles/ Views and analysis

Raising the bar: can Gilead’s next challenge be even bigger than Hep C?

Andrew McConaghie Gilead, Harvoni, hepatitis B, hepatitis C, HIV, Norbert Bischofberger, Sovaldi 0 Comment

How do you follow a genuine drug breakthrough, a cure for hepatitis C? Andrew McConaghie visits Gilead’s headquarters

Raising the bar: can Gilead’s next challenge be even bigger than Hep C?

https://pharmaphorum.com/views-and-analysis/raising-the-bar-can-gilead-s-next-challenge-be-even-bigger-than-hep-c/

Articles/ Views and analysis

NICE calls the shots on Harvoni – but NHS England eyeing price controls

Linda Banks Gilead, Harvoni, hepatitis C, NHS England, NICE 0 Comment

Harvoni and rival hep C drugs look set for approval in England – but NHS England may have

NICE calls the shots on Harvoni – but NHS England eyeing price controls

https://pharmaphorum.com/views-and-analysis/nice-calls-the-shots-on-harvoni-but-nhse-eyeing-price-controls/

News/ UK & Europe

AbbVie’s hep C combination approved in Europe

Andrew McConaghie AbbVie, Europe, Gilead, HCV, Hep C 0 Comment

AbbVie aiming to steal market share from Gilead

AbbVie’s hep C combination approved in Europe

https://pharmaphorum.com/news/abbvies-hep-c-combination-approved-in-europe/

Trending

Gilead

Login